Quick Takeaways
- Thomas Malley has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $18,753,279.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Thomas Malley
- Location
- Hamilton, Bermuda
- Summary
- The estimated net worth of Thomas Malley is at least $18,753,279 dollars as of 20 Mar 2026. Thomas Malley is the Director of BeiGene, Ltd. and owns shares of BeOne Medicines Ltd. (ONC) stock worth about $15.11M. Thomas Malley is the Director of Kiniksa Pharmaceuticals International, plc and owns shares of Kiniksa Pharmaceuticals International, plc (KNSA) stock worth about $2.39M. Thomas Malley is the Director of Kura Oncology, Inc. and owns shares of Kura Oncology, Inc. (KURA) stock worth about $1.25M.
- Signature
- /s/ Teresa Bair, Attorney-in-fact for Thomas Malley
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Thomas Malley and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: BeiGene, Ltd. ($15,114,558).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Thomas Malley
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ONC, BEIGF | BeiGene, Ltd. | Director | $15,114,558 | 15 Jun 2023 | ||
| KNSA | Kiniksa Pharmaceuticals International, plc | Director | $2,389,921 | -$5,859,815 | -71% | 12 Aug 2025 |
| KURA | Kura Oncology, Inc. | Director | $1,248,800 | 18 Mar 2026 |
Insider Transactions Reported by Thomas Malley:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.